Skip to main content
Log in

Tissue distribution of doxorubicin associated with polyisohexylcyanoacrylate nanoparticles

  • Published:
Cancer Chemotherapy and Pharmacology Aims and scope Submit manuscript

Summary

The body distribution of i. v. doxorubicin depends mainly on the physicochemical characteristics of the molecule. However, entrapment of that cytostatic drug inside polyalkylcyanoacrylate nanoparticles has been shown to modify its distribution profoundly in the mouse. Polyisohexylcyanoacrylate nanoparticles loaded with [14C]-doxorubicin were studied in comparison with free drug, with emphasis on their distribution pattern in mouse tissue after i. v. administration. An autoradiographic study showed that most of the radioactivity was found in the reticuloendothelial system as soon as a few minutes after i. v. administration of the doxorubicin-loaded nanoparticles. Quantitative determinations by liquid scintillation counting in fresh tissue (spleen, heart, kidneys, liver, lungs, bone marrow) and blood samples confirmed these observations. When the drug was linked to nanoparticles, doxorubicin blood clearance was reduced during the first few minutes after administration, whereas heart and kidney concentrations were substantially decreased. Assays of doxorubicin and doxorubicinol by a specific HPLC analytical method gave results very similar to those obtained by scintillation counting.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Brasseur F, Couvreur P, Kante B, Passau L, Roland M, Deckers C, Speiser P (1980) Actinomycin D adsorbed on polymethylcyanoacrylate nanoparticles increased efficiency against an experimental tumor. Eur J Cancer 16: 1441

    PubMed  CAS  Google Scholar 

  2. Chianilkulchai N, Driouich Z, Benoit JP, Gantier JC, Couvreur P (1989) Doxorubicin-loaded nanoparticles: increased efficiency in murine hepatic metastases. Cancer Drug Deliv (in press)

  3. Couvreur P, Kante B, Grislain L, Roland M, Speiser P (1982) Toxicity of polyalkylcyanoacrylate nanoparticles: II. Doxorubicin-loaded nanoparticles. J Pharm Sci 71: 790

    Article  PubMed  CAS  Google Scholar 

  4. Donnelly EF, Johnston DS, Pepper DC, Dunn DJ (1977) Ionic and zwitterionic polymerization ofn-alkyl-2-cyanoalkylacrylates (Letter to the editor). Polymer 15: 399

    CAS  Google Scholar 

  5. Lefrak E, Pitha J, Rosenheim S, Gottlieb J (1973) A clinicopathologic analysis of Adriamycin cardiotoxicity. Cancer 32: 302

    Article  PubMed  CAS  Google Scholar 

  6. Lenaerts V, Nagelkerke JF, Van Berkel TJC, Couvreur P, Grislain L, Roland M, Speiser P (1984) In vivo uptake of polyisobutylcyanoacrylate nanoparticles by liver Kupffer, endothelial and parenchymal cells. J Pharm Sci 73: 980

    Article  PubMed  CAS  Google Scholar 

  7. Lenaerts V, Couvreur P, Christiaens-Leyh D, Joiris E, Roland M, Rollman B, Speiser P (1984) Degradation of poly(isobutylcyanoacrylate) nanoparticles. Biomaterials 5: 65

    Article  PubMed  CAS  Google Scholar 

  8. Peterson J (1969) A carbon dioxide collection accessory for the rapid combustion apparatus for preparation of biological samples for liquid scintillation analysis. Anal Biochem 31: 204

    Article  CAS  Google Scholar 

  9. Pierce RN, Jatlow PI (1979) Measurement of Adriamycin (doxorubicin) and its metabolites in human plasma using reversed-phase high-performance liquid chromatography and fluorescence detection. J Chromatogr 164: 471

    Article  PubMed  CAS  Google Scholar 

  10. Rahman A, Carmichael D, Harris M, Roh JK (1986) Comparative pharmacokinetics of free doxorubicin entrapped in cardiolopin liposomes. Cancer Res 46: 2295

    PubMed  CAS  Google Scholar 

  11. Rolland A (1987) Mise au point et application de nanosphères à base de copolymères méthacryliques. Intérêts pour la vectorisation d’agents cytostatiques (anthracyclines). Ph.D. Thesis, University of Rennes I

  12. Ullberg S (1954) Studies on the distribution and fate of S35-labelled benzylpenicillin in the body. Acta Radiol 118: 1

    CAS  Google Scholar 

  13. Verdun C, Couvreur P, Vranckx H, Lenaerts V, Roland M (1986) Development of a nanoparticle controlled-release formulation for human use. J Controlled Release 3: 205

    Article  CAS  Google Scholar 

  14. Wilmott N, Cummings J, Stuart JBF, Florence AT (1985) Adriamycin-loaded albumin microspheres: preparation, in vivo distribution and release in the rat. Biopharm Drug Dispos 6: 91

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Verdun, C., Brasseur, F., Vranckx, H. et al. Tissue distribution of doxorubicin associated with polyisohexylcyanoacrylate nanoparticles. Cancer Chemother Pharmacol 26, 13–18 (1990). https://doi.org/10.1007/BF02940287

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02940287

Keywords

Navigation